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a b s t r a c t
Metallothioneins (MTs) constitute a superfamily of ubiquitous metal-binding proteins of low molecu-
lar weight and high Cys content. They are involved in metal homeostasis and detoxiﬁcation, amongst
other proposed biological functions. Two MT isoforms (SpMTA and SpMTB) have been reported in the
echinoderm Strongylocentrotus purpuratus (sea urchin), both containing 20 Cys residues and present-
ing extremely similar sequences, although showing distinct tissular and ontogenic expression patterns.
Although exhaustive information is available for the Cd(II)-SpMTA complex, this including the full
resolution of its 3D structure, no data has been reported concerning either SpMTA Zn(II) and Cu(I)
binding properties, or the characterization of SpMTB at protein level. In this work, both the SpMTA
and SpMTB isoforms, as well as their separate α and β domains, have been recombinantly synthesized
in the presence of Zn(II), Cd(II) or Cu(II), and the corresponding metal complexes have been analyzed
using electrospray mass spectrometry, and CD, ICP-AES and UV–vis spectroscopies. The results clearly
show a better performance of isoform A when binding Zn(II) and Cd(II), and of isoform B when coordi-
nating Cu(I). Thus, our results conﬁrm the differential metal binding preference of SpMTA and SpMTB,
which, together with the reported induction pattern of the respective genes, highlights how also in
Echinodermata the MT polymorphismmay be linked to the evolution of different physiological roles.
C© 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies.Open access under CC BY-NC-ND license.1. Introduction
Metallothioneins (MTs) are a superfamily of universal and ubiq-
uitous low molecular weight proteins that bind essential and toxic
metal ions through their abundant Cys residues, formingmultinuclear
metal–thiolate clusters. They are involved in many crucial biological
processes, such as metal homeostasis and detoxiﬁcation, or oxidative
stress protection, among others [1]. Although their protein sequences
are dramatically heterogeneous and consequently their classiﬁcation
is not a trivial affair, their metal-binding behavior converges to either
Zn-thioneins, which show a binding preference for divalent metal
ions, or Cu-thioneins, with an optimized coordination of monovalent
metal ions [2]. Beyond this simplistic dual model, the comprehensive
consideration of the metal-binding features of a huge number of MT
peptides later led to the proposal of a continuous gradation between* Corresponding author. Address: Unitat Quı´mica Inorga`nica, Departament de
Quı´mica, Facultat de Cie`ncies, Universitat Auto`noma de Barcelona, Bellaterra 08193,
Catalonia, Spain. Tel.: +34 935812886; fax: +34 935812477.
E-mail address: Roger.Boﬁll@uab.cat (R. Boﬁll).
2211-5463 c© 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of Europe
http://dx.doi.org/10.1016/j.fob.2013.01.005both extreme behaviors [3]. Unfortunately, the sequence determi-
nants of themetal speciﬁcity of MTs are still unknown [4], although it
should be considered a key element for a better understanding of the
evolutive differentiation [5] and physiological function of these pecu-
liar metalloproteins [6]. Polymorphism is one of the most signiﬁcant
features ofMTs, since at least all the eukaryote organisms studied un-
til now exhibitMT systems composed of almost similar paralog forms
[5]. Ideally, each isoformwould correspond to a deﬁnite physiological
function, but it is plainly evident that in most cases ontogenic, tissu-
lar and/or functional differentiation has not been achieved, so that
no clear correlation exists betweenmultiple MT isoforms and their in
vivo performance.
In this scenario, and with the aim of gathering data on the most
prominent model organisms, we undertook the characterization of
the metal-binding preferences of the purple sea urchin (Strongylo-
centrotus purpuratus, echinoderm) MT isoforms. Echinodermata con-
stitute a very interesting phylum since, as the unique invertebrate
deuterostomes, they are evolutively close to the Chordates, which are
also deuterostomes (for a recent review on Echinodermata MTs, see
[7]). At genomic level, seven different homologous MT genes have
been reported in S. purpuratus, of which only three produce biologi-
cally relevant isoforms: SpMTA and the pair SpMTB1–SpMTB2, the lat-
ter encoding proteins with identical sequence [8–10]. Signiﬁcantly,an Biochemical Societies. Open access under CC BY-NC-ND license.
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Fig. 1. (A) Amino acid sequence alignment of recombinant SpMTA and SpMTB. Note
that the N-term Gly–Ser residues derive from the GST-fusion system used for recom-
binant synthesis and puriﬁcation. (B) 3D structures of Cd4-αSpMTA (top) and Cd3-
βSpMTA (bottom) generated from PDB ﬁles 1QJK and 1QJL, respectively, with VMD
software (http://www.ks.uiuc.edu/Research/vmd/) [Humphrey W, Dalke A, Schulten
K. VMD – visual molecular dynamics. J. Molec. Graphics 1996;14:33–38]. Color code:
random coil, silver; turn, cyan; extended beta, orange; Cd(II) ions, purple; Cys residue
backbone and Cys-Cd connectivities, yellow. N-term and C-term ends of SpMTA se-
quence are indicated, and an arrowmarks the position of the insertion of a Thr residue
in SpMTB. (For interpretation of the references to color in this ﬁgure legend, the reader
is referred to the web version of this article.)
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ppMTA and SpMTB exhibit different quantitative tissular and tempo-
al expression patterns. Hence, SpMTA is transcribed in ectodermal
issues, while SpMTB is expressed in both the ectodermal and endo-
ermal structures. Both genes are constitutively expressed, and un-
er physiological conditions SpMTAmRNA levels reach up to 10 times
hose of SpMTB. However, under metal (zinc or cadmium) overload,
pMTB expression is further induced, so that SpMTB achieves protein
evels similar to those of SpMTA [8,10].
SpMTA is a 64-amino acid peptide including 20 Cys, while the
pMTB sequence is two amino acids longer, with fully conserved Cys
nd only 10 residue substitutions (Fig. 1(A)), although some other
hanges have been detected in minor EST clones, attributable to nat-
ral polymorphism. Of both isoforms, only the study of SpMTA has
ttracted great interest, since the Cys–Cys motifs typical of the C-
erminalmoiety (orαdomain)of themammalianMTsare locatedhere
n theN-terminalmoiety, and vice versa for the Cys–X–Cysmotifs typ-
cal of the N-terminal half (or β domain) of the mammalian MTs (Fig.
(A)). This inverted arrangement led to propose a speciﬁc evolution-
ry theory for the origin of differentMTproteins, basedon considering
he number and position of the binding domains in differentMTs [11].
hereafter, several structural features of the Cd-SpMTA complexes
ere revealed by the work in the laboratory of Prof. Ka¨gi on recom-
inant SpMTA [12–14], which culminated with the determination
f the three-dimensional structure of reconstituted-113Cd7-SpMTA,
olved by NMR in 1999 (Fig. 1(B)) [15]. These results conﬁrmed that
he global structure of each Cd7-SpMTA domain resembled that of
he mammalian MTs, although a signiﬁcantly different connectivity
attern of the Cd–S bonds and novel local polypeptide folds arose inSpMTA. Precisely, two globular domains separated by a ﬂexible hinge
and encompassing a Cd4(SCys)11 and a Cd3(SCys)9 cluster in an in-
verted order with respect to mammalian MTs were encountered. The
Cd4(SCys)11 cluster (in the N-term protein α domain) consisted of the
union of 2 six-membered rings sharing 2 Cd–S bonds, thus including
5 bridging and 6 terminal S atoms, whereas the Cd3(SCys)9 cluster
(in the C-term protein β domain) consisted of 3 cadmium ions and 3
bridging Cys thiolates forming a six-membered ring, while the other
six Cys acted as terminal ligands. Although it was not possible to de-
termine the mutual orientation of the two domains, it was evident
that both were twisted to the left around the metal–thiolate cluster.
This constrasts with the mammalian MT complexes, where the β do-
main is wrapped with right-handed chirality, thus representing the
only known example of left-handed β domain.
This exhaustive information on the complexes yielded by SpMTA
upon divalentmetal ion coordination contrastswith the null informa-
tion about its copper binding abilities nor about metal ion handling
by SpMTB. Therefore, in order to gain an insight into the evolutive
signiﬁcance of the two different MT isoforms in sea urchin, we aimed
at performing a comparative study of their metal ion coordination
features. To this end, this work describes the Zn(II), Cd(II) and Cu(I)-
binding abilities of recombinant SpMTA and SpMTB, aswell as of their
separate domains, in order to determine their metal binding behav-
ior and preferences. The consideration of all the obtained results is
consistent with a higher Zn/Cd-thionein character for SpMTA, and a
better performance of SpMTB when binding copper, and they con-
ﬁrm that a slight but consistent difference between the physiological
functions of both isoforms may be envisaged.
2. Materials and methods
2.1. Cloning of MT cDNA constructs
All the metal-MT complexes investigated in the present study
were recombinantly synthesized in Escherichia coli through cloning
of their coding sequences into the pGEX-4T1 plasmid (GE Health-
care, Little Chalfont, UK) to yield primary glutathione S-transferase
(GST)-MT fusions from which the corresponding metal-MT com-
plexes were subsequently puriﬁed [16,17]. The SpMTA cDNA
was kindly provided by Prof. Ka¨gi and subsequently cloned into
the pGEX-4T1 BamHI/SalI restriction sites added by PCR ampli-
ﬁcation, using 5′-CCCGGATCCATGCCTGATGTCAAG-3′ as upstream
primer and 5′-GCGCCCGTCGACCTAGCATGCACA-3′ as downstream
primer. According to the reported SpMTA domain boundaries
[15], cDNAs encoding for its separate moieties were obtained
by PCR reactions that added BamHI/XhoI restriction sites with
the following oligonucleotides: for the N-terminal fragment or
α domain (encompassing residues 1–36 of the full polypep-
tide), 5′-CCCGGATCCATGCCTGATGTCAAG-3′ (upstream) and 5′-
AAACTCGAGTCATCCACAGCAGGTTCCATCCTTG-3′ (downstream); and
for the C-terminal fragment or β domain (residues 37–64 of the
full polypeptide), 5′-ACACACGGATCCATATGCACAAACGCTGCATGC-
3′ (upstream) and 5′-AAACCCCTCGAGCTAGCATGCACAGTTCCCCTC-
3′ (downstream). The cDNA of the SpMTB isoform was obtained
from the Sea Urchin Genome Project Library Collection, in the Cal-
ifornia Institute of Technology (Caltech), and corresponded to the
EST clone PMC 62379562 (seq ID NCBI 214576). The correspond-
ing ORF was ampliﬁed by a PCR reaction that added BamHI/XhoI
restriction sites to the respective 5′ and 3′ ends of the coding se-
quence, using the puriﬁed cDNA of the EST clone as template and the
following primers: 5′-CCCGGATCCATGCCTGATGTCAAGTGTGTCTGC-
3′ (upstream) and 5′-AAACCCCTCGAGCTAGCATGGACAGTTCCCCTC-
3′ (downstream). Based on the reported domain boundaries
of SpMTA [15], cDNAs encoding for the separate SpMTB
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Fig. 2. Representative charge states for the ESI-MS spectra recorded at pH 7.0 of recombinant Zn-SpMTA (A), Zn-αSpMTA (B), Zn-βSpMTA (C), Zn-SpMTB (D), Zn-αSpMTB (E) and
Zn-βSpMTB (F). The observed species are collected in Table 2.moieties were obtained by PCR reactions with the follow-
ing oligonucleotides: for the N-terminal fragment or α do-
main (encompassing residues 1–37 of the full polypeptide), 5′-
CCCGGATCCATGCCTGATGTCAAGTGTGTCTGC-3′ (upstream) and 5′-
AAACTCGAGTCATCCAGTGCAGCAGGTTCCACC-3′ (downstream); and
for the C-terminal fragment or β domain (residues 38–66 of the
full polypeptide), 5′-ACACACGGATCCAAATGCTCAAATGCGGCATGC-
3′ (upstream) and 5′-AAACCCCTCGAGCTAGCATGGACAGTTCCCCTC-3′
(downstream). All the PCR reactions consisted of 35-cycle ampliﬁca-
tions, performed with 1.25 U of GoTaq DNA polymerase (Promega,
Madison, USA), 0.25 mM dNTPs and 0.24 μM of the required primers
at 2mMMgCl2 (ﬁnal concentration), in a ﬁnal volumeof 100μL, under
the following cycle conditions: 30 s at 94 ◦C (denaturation), 30 s at 58
◦C (hybridization) and 30 s at 72 ◦C (elongation). An initial denatura-
tion step where samples were heated at 94 ◦C for 2 min ensured that
the target DNAwas completely denatured, and elongation conditions
were maintained for 7 min after the 35 cycles. The ﬁnal products
were analyzed by agarose gel electrophoresis/GelRed Nucleic Acid
Gel Stain (Biotium, Hayward, CA, USA) staining; the band with the
expected size was excised and subcloned into the pGEX-4T1 vector.
Before recombinant protein synthesis, all coding sequenceswere con-
ﬁrmed by automated DNA sequencing. To this end, the pGEX-derived
constructswere transformed into E. coliMATCH I cells, and sequenced
using the ABI PRISM BigDye Terminator v3.1 Cycle Sequencing Kit
(Applied Biosystems, Foster City, CA, USA) in an ABI PRISM 310 Au-
tomatic Sequencer (Applied Biosystems, Foster City, CA, USA). In all
cases, the expected sequence was corroborated.
2.2. Recombinant synthesis and puriﬁcation of metal-MT complexes
The SpMTA-GST and SpMTB-GST fusion polypeptides and their re-
spective separateα andβdomainswere biosynthesized in 5 L cultures
of transformedprotease-deﬁcient E. coliBL21 cells. Expressionwas in-
duced with isopropyl β-d-thiogalactopyranoside (IPTG) and cultures
were supplemented with 500 μM CuSO4, 300 μM ZnCl2 or 300 μM
CdCl2 (ﬁnal concentrations) and were allowed to grow for a further 3
h. In the case of Cu(II)-enriched cultures, both normal and low aera-
tion conditions (N.A. and L.A., respectively)were assayed according to
the procedure described elsewhere [18]. A total protein extract was
prepared from these cells as previously described [16]. Metal com-
plexes were recovered from the MT-GST fusion constructs by throm-
bin cleavage and batch-afﬁnity chromatography using Glutathione-
Sepharose 4B (General Electric HC). Themetal complexeswere ﬁnallypuriﬁed through FPLC in a Superdex75 column (General Electric HC)
equilibrated with 50 mM Tris–HCl, pH 7.0. Selected fractions were
conﬁrmed by 15% SDS–PAGE and kept at −80 ◦C until further use.
All procedures were performed using Ar (pure grade 5.6) saturated
buffers, and all syntheses were performed at least twice to ensure
reproducibility. Further details on the puriﬁcation procedure can be
found in [16]. As a consequence of the cloning requirements, the
dipeptide Gly–Ser was present at the N-terminus of all polypeptides;
however, this had previously been shown not to alter the MT metal-
binding capacities [17].
2.3. In vitro Cd- and Cu-binding studies
The titration of all Zn-MT complexes with Cd(II) or Cu(I) at pH
7 were carried out following the methodology previously described
[19,20], using CdCl2 or [Cu(CH3CN)4]ClO4 solutions, respectively. The
acidiﬁcation/reneutralization experiments were also performed by
adapting the procedure reported in [21]. Essentially, 10–20μMprepa-
rations of the Cd-peptides were acidiﬁed from pH 7.0 to pH 1.0–2.0
with 1 × 10−3 M HCl. CD and UV–vis spectra were recorded at sev-
eral pH values both immediately after acid addition and 10 min later,
alwayswith identical results. Finally, the sampleswerekept atpH1.0–
2.0 for 20 min and were then reneutralized with 1 × 10−3 M NaOH,
and CD and UV–vis spectra were recorded at several pH values. In
some cases, several molar equivalents of an aqueous solution of Na2S
were added to the reneutralizedMT forms, with the aim of reproduc-
ing the original Cd-MT CD ﬁngerprints. All results were corrected for
dilution effects, and during all experiments strict oxygen-free condi-
tions were kept by saturating all solutions with Ar.
2.4. Protein quantiﬁcation and spectroscopic analyses
The S, Zn, Cd and Cu content of the Zn-, Cd- and Cu-MT prepara-
tions was analyzed by means of Inductively Coupled Plasma Atomic
Emission Spectroscopy (ICP-AES) in a Polyscan 61E (Thermo Jarrell
Ash) spectrometer, measuring S at 182.040 nm, Zn at 213.856 nm, Cd
at 228.802 and Cu at 324.803 nm. Samples were treated as in [22],
but were alternatively incubated in 1MHCl at 65 ◦C for 5min prior to
measurements, in order to eliminate possible traces of labile sulﬁde
ions, as otherwise described [23]. Protein concentrations were calcu-
lated from the acid ICP-AES sulfur measurement, assuming that all S
atoms were contributed by the MT peptide. A Jasco spectropolarime-
ter (Model J-715) interfaced to a computer (J700 software) was used
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Table 1
List of theoretical and experimental molecular weights (MW) corresponding to the
apoforms of the six recombinantly synthesized polypeptides.
MT Theoretical MW Experimental MW
SpMTA 6532.0 6534.9 ± 0.8
αSpMTA 3874.0 3873.9 ± 0.4
βSpMTA 2820.2 2819.6 ± 0.5
SpMTB 6700.7 6698.6 ± 0.4
αSpMTB 3913.5 3912.4 ± 0.1
βSpMTB 2949.3 2948.6 ± 0.4
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Fig. 3. CD spectra corresponding to the entire MT (A) and the separate constitutive α
(B) and β (C) domains of SpMTA (black) and SpMTB (red) recombinantly synthesized
in Zn-supplemented media. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)or CD measurements at a constant temperature of 25 ◦C maintained
y a Peltier PTC-351S apparatus. Electronic absorptionmeasurements
ere performed on an HP-8453 Diode array UV–vis spectrophotome-
er. All spectra were recorded with 1 cm capped quartz cuvettes,
orrected for the dilution effects and processed using the GRAMS 32
oftware.
.5. Mass spectrometry
MW determinations were performed by electrospray ionization
ime-of-ﬂight mass spectrometry (ESI-TOF MS) on a Micro Tof-Q in-
trument (Bruker) interfaced with a Series 1100 HPLC Agilent pump,
quipped with an autosampler, all of which were controlled by the
ompass Software. Calibration was attained with 0.2 g NaI dissolved
n 100 mL of a 1:1 H2O:isopropanol mixture. Samples containing MT
omplexes with divalent metal ions were analyzed under the fol-
owing conditions: 20 μL of protein solution injected through a PEEK
polyether heteroketone) column (1.5 m × 0.18 mm i.d.), at 40 μL
in−1; capillary counter-electrode voltage 5 kV; desolvation temper-
ture90–110 ◦C;drygas6 Lmin−1; spectra collection range800–2000
/z. The carrier buffer was a 5:95mixture of acetonitrile:ammonium
cetate/ammonia (15 mM, pH 7.0). Alternatively, the Cu-MT samples
ere analyzed as follows: 20 μL of protein solution injected at 30
L min−1; capillary counter-electrode voltage 3.5 kV; lens counter-
lectrodevoltage4kV;dry temperature80 ◦C;dry gas6 Lmin−1.Here,
he carrier was a 10:90 mixture of acetonitrile:ammonium acetate/
mmonia (15mM, pH 7.0). For analysis of all recombinant MTmolec-
larmasses, 20 μL of the corresponding Zn-MT sampleswere injected
nder the same conditions described before, but using a 5:95mixture
f acetonitrile:formic acid pH 2.5 as liquid carrier, which caused the
omplete demetalation of the peptides. The same conditions were
hen used to remove Zn(II) ions frommixed-metal Zn, Cu-MT species
n order to quantify their total Cu content.
. Results and discussion
.1. Integrity and identity of the recombinant polypeptides
The cDNAs coding for the SpMTA and SpMTB isoforms as well as
or their separate domains were cloned into the pGEX-4T1 plasmid
or peptide synthesis. DNA sequencing conﬁrmed that all these con-
tructs included no artifactual nucleotide substitutions, and that the
espective coding sequences were cloned in the correct frame after
he GST encoding fragment. Recombinant syntheses yielded MT pep-
ides of which the identity, purity and integrity was conﬁrmed by
SI-MS of the respective apoforms, obtained by acidiﬁcation at pH 2.5
f the corresponding Zn-MT complexes. Hence, in each synthesis a
nique peak was detected, in which the MWwas consistent with the
alculated MW of the respective recombinant MT peptide, including
-terminal Gly–Ser residues derived from the GST-fusion construct
Table 1).3.2. SpMTA exhibits better Zn(II) and Cd(II) binding abilities than
SpMTB
Both SpMTA and SpMTB yield a major Zn7-MT species when re-
combinantly synthesized as Zn(II)-complexes (Table 2, Fig. 2(A) and
(D)), although the occurrence of several minor undermetalated, par-
tially oxidized species ismarkedly signiﬁcant for SpMTB,where all the
species ranging from Zn6 to Zn3 are produced (Fig. 2(D)). This result
already suggests a lower ZnII-binding ability for SpMTB compared
to SpMTA. The CD ﬁngerprints of both Zn-preparations are similar
and characteristic of Zn-MT complexes (Fig. 3(A)), and the ca. 10 nm
red-shift of Zn-SpMTB is attributable to the differences between the
respective β domains, as analyzed below.
When synthesized in the presence of Cd(II), SpMTA yields a major
Cd7 species (Fig. 4(A)), whose CD ﬁngerprint shows an intense exci-
ton coupling centered at 250 nm (Fig. 5(A)) typical of type A Cd-MT
complexes [23], andwhich is also very similar to theCD spectrumpre-
viously reported for recombinant Cd7-SpMTA [12,13]. Even though a
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Table 2
Analytical characterization of recombinant SpMTA and SpMTB and their independent constitutive fragments synthesized in (A) Zn- and (B) Cd-enriched media.
MT Concentration and metal/MT
ratioa
ESI-MSb
Species (% abundance) Theoretical MW Experimental MW
A
SpMTA 3.2 × 10−4 M Zn7-SpMTA (100) 6976.1 6978.8 ± 0.9
6.1 Zn Zn7S1-SpMTA (30) 7010.2 7016.5 ± 2.5
Zn4-SpMTA (20) 6786.0 6780.9 ± 0.2
Zn3-SpMTA (20) 6722.6 6715.9 ± 0.6
αSpMTA 0.9 × 10−4 M Zn4-αSpMTA 4127.5 4127.2 ± 0.1
3.8 Zn
βSpMTA 0.7 × 10−4 M Zn3-βSpMTA (100) 3010.3 3009.9 ± 0.1
2.3 Zn Zn2-βSpMTA (30) 2947.0 2943.8 ± 1.5
apo-βSpMTA (30) 2820.2 2811.0 ± 1.3
Zn1-βSpMTA (20) 2883.6 2877.0 ± 1.2
SpMTB 2.3 × 10−4 M Zn7-SpMTB (100) 7144.4 7143.5 ± 0.5
5.2 Zn Zn6-SpMTB (50) 7081.0 7076.9 ± 1.3
Zn5-SpMTB (50) 7017.6 7012.9 ± 1.1
Zn4-SpMTB (60) 6954.3 6944.0 ± 0.9
Zn3-SpMTB (20) 6890.9 6880.0 ± 1.4
αSpMTB 2.2 × 10−4 M Zn4-αSpMTB 4167.0 4166.1 ± 0.1
3.8 Zn
βSpMTB 0.8 × 10−4 M Zn3-βSpMTB 3139.5 3138.9 ± 0.1
3.1 Zn
B
SpMTA 0.7 × 10−4 M Cd7-SpMTA (100) 7305.3 7304.5 ± 0.5
7.7 Cd Cd7S1-SpMTA (20) 7339.4 7341.6 ± 1.8
0.0 Zn
αSpMTA 0.7 × 10−4 M Cd4-αSpMTA 4315.6 4316.1 ± 0.1
3.9 Cd
0.0 Zn
βSpMTA 0.2 × 10−4 M Cd3-βSpMTA (100) 3151.4 3151.8 ± 0.4
2.8 Cd Cd3Zn1-βSpMTA (30) 3214.8 3215.6 ± 0.6
0.4 Zn
SpMTB 0.8 × 10−4 M Cd8-SpMTB (100) 7583.9 7584.1 ± 0.5
6.7 Cd Cd7S2-SpMTB (50) 7541.6 7534.4 ± 0.9
0.0 Zn Cd7-SpMTB (40) 7473.5 7474.8 ± 0.4
αSpMTB 1.3 × 10−4 M Cd4-αSpMTB 4355.1 4355.5 ± 0.4
4.0 Cd
0.0 Zn
βSpMTB 0.8 × 10−4 M Cd3S2-βSpMTB (100) 3348.7 3343.1 ± 0.5
2.9 Cd Cd3-βSpMTB (40) 3280.5 3280.8 ± 0.3
0.0 Zn
a
MT concentration and metal/MT ratio calculated from acid ICP-AES results.
b
Experimental and theoretical molecular weights corresponding to the Zn- and Cd-peptides. Zn and Cd contents were calculated from the mass difference between holo- and
apoproteins. Species shown in bold correspond to the major components of the preparations.very minor Cd7S1 species was identiﬁed in the Cd-SpMTA prepara-
tion (Table 2, Fig. 4(A)), its relative abundance is practically negli-
gible if compared with the minor forms detected in Cd-SpMTB (Fig.
4(D)). In this case, an unexpected major Cd8 species was produced,
together with several signiﬁcantly abundant minor species, among
which Cd7- and Cd7S2-SpMTB are worth noting (Table 2, Fig. 4(D)).
The CD ﬁngerprint of this preparation differs from that of Cd-SpMTA,
being signiﬁcantly less intense and conﬁrming the presence of sul-
ﬁde ligands through the existence of the negative band at 280 nm
(Fig. 5(A)). The occurrence of numerous species in the recombinant
Cd-SpMTB preparation, some of which have a clear sulﬁde content, is
again indicative of a lowCdII-binding ability of SpMTB, as occurred for
Zn(II) ions, according to the criteria reported by our group to differ-
entiate MT peptides exhibiting either divalent or monovalent metal
ion coordination preference [3].
The Zn(II) and Cd(II) binding abilities of the separate α domains
appeared identical for both isoforms, generating almost single Zn4
and Cd4 species (Figs. 2(B) and (E), and 4(B) and (E), respectively, and
Table 2), also with similar CD ﬁngerprints (Figs. 3(B) and 5(B)). In the
case of Cd4-αSpMTA, the spectrum fully coincides with that previ-
ously reported after subtilisin digestion of the complete Cd7-SpMTA
complex [14]. Moreover, this spectrum can be also obtained by Zn/Cd
replacement after the addition of 4 Cd(II) equivalents to Zn4-αSpMTA
at pH 7 (Fig. 6). In contrast to these results, the βSpMTA and βSpMTB
domains yield patently different results when synthesized in Zn(II)-and Cd(II)-enriched media. Hence, both isoforms are recovered as
major Zn3 complexes, although the partially undermetalated species
detectable for SpMTA do not appear for SpMTB (Table 2, Fig. 2(C) and
(F)). Also, as determined from the difference between conventional
and acid ICP-AES measurements (data not shown), the presence of
inorganic sulﬁde in the recombinant Zn-βSpMTB preparations may
account for the red-shift observed for Zn-βSpMTB CD spectrum in
comparison to Zn-βSpMTA (Fig. 3(C)). Even more pronounced differ-
ences arise for the CdII-binding capacity of the separate β domains, as
βSpMTA yields a major, canonical Cd3 species accompanied byminor
Zn-containing complexes, while βSpMTB predominantly folds into
Cd3S2-βSpMTB, thus with complete absence of Zn (Fig. 4(C) and (F),
respectively, and Table 2). Moreover, the Cd3S2-βSpMTB sulﬁde con-
taining complex exhibits an acute red-shift in its CD spectrum when
compared to Cd3-βSpMTA (Fig. 5(C)).
At this point, it becomes evident that the Cd-binding abilities of
SpMTB are poorer than those of SpMTA [3], and that this feature is
most likely due to a patent lower MII-binding ability of βSpMTB if
compared to βSpMTA, as corroborated by the fact that the respective
α domains exhibit nomajor differences. In order to better understand
the peculiarities of the Cd-SpMTA and Cd-SpMTB complexes, and to
support the higher MII-binding preference of βSpMTA compared to
βSpMTB, additional experimental results were considered. In the ﬁrst
place, it is worth noting that the CD spectra of the Zn/Cd replacement
processes in both β domains evolved following a distinct pattern,
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Fig. 4. Representative charge states for the ESI-MS spectra recorded at pH 7.0 of recombinant Cd-SpMTA (A), Cd-αSpMTA (B), Cd-βSpMTA (C), Cd-SpMTB (D), Cd-αSpMTB (E) and
Cd-βSpMTB (F). The observed species are collected in Table 2.
Table 3
Analytical characterization of recombinant SpMTA and its independent constitutive fragments synthesized in Cu-enriched media under normal (N.A.) and low (L.A.) aeration
conditions.
MT
Concentration and
metal/MT ratioa ESI-MSb
Species (% abundance) Theoretical MW Experimental MW
SpMTA (N.A.) 0.5 × 10−4 M pH 7.0 M4-SpMTA (100) 6782.7–6786.0 6771.0 ± 0.1
5.5 Cu M8-SpMTA (80) 7032.8–7039.5 7029.7 ± 1.2
3.0 Zn M5-SpMTA (40) 6845.2–6849.4 6838.0 ± 1.1
M9-SpMTA (40) 7095.3–7102.9 7092.5 ± 1.5
M6-SpMTA (30) 6907.7–6912.8 6899.8 ± 1.3
pH 2.5 Cu4-SpMTA (100) 6782.7 6773.5 ± 0.5
Cu8-SpMTA (20) 7032.8 7035.3 ± 2.2
Apo-SpMTA (20) 6532.0 6522.5 ± 2.3
SpMTA (L.A.) 0.5 × 10−4 M pH 7.0 M8-SpMTA (100) 7032.8–7039.5 7030.6 ± 0.8
8.7 Cu M11-SpMTA (60) 7220.4–7229.6 7224.6 ± 0.3
1.7 Zn M9-SpMTA (60) 7095.3–7102.9 7096.8 ± 1.0
M10-SpMTA (40) 7157.9–7166.2 7161.4 ± 1.2
pH 2.5 Cu8-SpMTA (100) 7032.8 7029.1 ± 1.2
Cu9-SpMTA (40) 7095.3 7094.1 ± 1.8
αSpMTA (N.A.) 0.3 × 10−4 M pH 7.0 Oxidized dimeric species – –
6.0 Cu pH 2.5 N.D. – –
0.1 Zn
αSpMTA (L.A.) 0.2 × 10−4 M pH 7.0 N.D. – –
4.2 Cu pH 2.5 Oxidized dimeric species – –
0.2 Zn
βSpMTA (N.A.) 0.7 × 10−4 M pH 7.0 M5-βSpMTA (100) 3132.9–3137.1 3129.6 ± 0.1
5.1 Cu M6-βSpMTA (30) 3195.5–3200.5 3195.6 ± 0.3
0.2 Zn M4-βSpMTA (20) 3070.4–3073.7 3067.6 ± 2.1
M7-βSpMTA (20) 3258.0–3263.8 3255.4 ± 1.9
pH 2.5 N.D. – –
βSpMTA (L.A.) 0.05 × 10−4 M pH 7.0 M5-βSpMTA (100) 3132.9–3137.1 3131.6 ± 1.6
3.4 Cu M4-βSpMTA (40) 3070.4–3073.7 3066.8 ± 1.9
0.7 Zn pH 2.5 N.D. – –
a
MT concentration and metal/MT ratio calculated from acid ICP-AES results.
b
Experimental and theoretical molecular weights corresponding to the Cu-peptides. Species shown in bold correspond to the major components of the preparations. In the case
of Zn, Cu mixed-metal species, the indicated theoretical molecular weights correspond to the homometallic Cux and Znx species (MWCu-MT–MWZn-MT), and the metal-to-protein
stoichiometries deduced at pH 7.0 are indicated as Mx (M = Zn + Cu). Cu contents at pH 2.5 were calculated from the mass difference between holo- and apoproteins. N.D.: not
detected.
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Table 4
Analytical characterization of recombinant SpMTB and its independent constitutive fragments synthesized in Cu-enriched media under normal (N.A.) and low (L.A.) aeration
conditions.
MT
Concentration and
metal/MT ratioa ESI-MSb
Species (% abundance) Theoretical MW Experimental MW
SpMTB (N.A.) 0.9 × 10−4 M pH 7.0 M8-SpMTB (100) 7201.1–7207.8 7196.1 ± 0.6
5.5 Cu M10-SpMTB (70) 7326.2–7334.6 7322.8 ± 1.0
1.9 Zn M9-SpMTB (60) 7263.7–7271.2 7260.8 ± 0.9
M11-SpMTB (20) 7388.8–7398.0 7387.6 ± 0.7
M5-SpMTB (20) 7013.5–7017.7 7002.8 ± 1.1
pH 2.5 Cu8-SpMTB (100) 7201.1 7196.0 ± 0.1
Cu4-SpMTB (40) 6950.9 6944.6 ± 1.1
Cu9-SpMTB (40) 7263.7 7261.0 ± 1.2
Cu5-SpMTB (20) 7013.5 7008.0 ± 1.6
SpMTB (L.A.) 0.2 × 10−4 M pH 7.0 and 2.5 N.D. – –
14.5 Cu
0.0 Zn
αSpMTB (N.A.) 0.6 × 10−4 M pH 7.0 M5-αSpMTB (100) 4226.2–4230.5 4223.0 ± 1.0
5.5 Cu M4-αSpMTB (70) 4163.7–4167.1 4159.2 ± 1.1
0.5 Zn M7-αSpMTB (60) 4351.3–4357.2 4350.0 ± 0.7
pH 2.5 Cu4-αSpMTB (100) 4163.7 4158.6 ± 0.6
Cu5-αSpMTB (80) 4226.2 4222.0 ± 0.9
Cu7-αSpMTB (40) 4351.3 4348.0 ± 1.2
αSpMTB (L.A.) 0.3 × 10−4 M pH 7.0 N.D. – –
7.0 Cu pH 2.5 Cu4-αSpMTB (100) 4163.7 4157.6 ± 0.5
0.0 Zn Cu5-αSpMTB (90) 4226.2 4221.9 ± 0.9
Apo-αSpMTB (90) 3913.5 3903.3 ± 0.1
βSpMTB (N.A.) 0.3 × 10−4 M pH 7.0 M5-βSpMTB (100) 3262.0–3266.3 3260.2 ± 0.4
3.3 Cu M7-βSpMTB (80) 3387.1–3393.0 3386.6 ± 0.8
0.2 Zn M8-βSpMTB (80) 3449.7–3456.4 3449.0 ± 0.5
M6-βSpMTB (40) 3324.6–3329.6 3322.6 ± 1.0
pH 2.5 Cu8-βSpMTB (100) 3449.7 3448.5 ± 0.1
Apo-βSpMTB (100) 2949.3 2940.9 ± 1.2
Cu4-βSpMTB (60) 3199.5 3195.3 ± 0.6
Cu5-βSpMTB (60) 3262.0 3259.7 ± 1.0
Cu7-βSpMTB (60) 3387.1 3385.5 ± 0.1
βSpMTB (L.A.) N.D. pH 7.0 and 2.5 N.D. – –
a
MT concentration and metal/MT ratio calculated from acid ICP-AES results.
b
Experimental and theoretical molecular weights corresponding to the Cu-peptides. Species shown in bold correspond to the major components of the preparations. In the case
of Zn, Cu mixed-metal species, the indicated theoretical molecular weights correspond to the homometallic Cux and Znx species (MWCu-MT–MWZn-MT), and the metal-to-protein
stoichiometries deduced at pH 7.0 are indicated as Mx (M = Zn + Cu). Cu contents at pH 2.5 were calculated from the mass difference between holo- and apoproteins. N.D.: not
detected.especially after the 3rd Cd(II) equivalent added (Fig. 7(A)–(D)). But
most interestingly, while the CD ﬁngerprint of the recombinant Cd-
βSpMTA preparation was reproduced after the 3rd Cd(II) equivalent
added to Zn-βSpMTA (Fig. 7(E)), this was not the case for βSpMTB,
even after the addition of 1–3 Na2S equivalents, which provoked the
conversion of the derivative-shaped band into a Gaussian band (Fig.
7(F)). For the Cd-βMTB isoform, the initial CD ﬁngerprint can only
be recovered after an acidiﬁcation/reneutralization process followed
by addition of 3 S2− equivalents (Fig. 7(G)). Taken together, these
data conﬁrm that βSpMTB shows a diminished preference for diva-
lent metal ion binding than βSpMTA, as highlighted by the need of
S2− ions in order to stabilize its M(II)-recombinant forms, and it is
likely that the β moiety somehow confers its character to the en-
tire SpMTB protein, which behaves as a less proﬁcient Cd(II)-binding
peptide. Since the analysis of the metal-binding behavior of a consid-
erable number of MTs has revealed that the decrease of the divalent
metal ion-preference (Zn(II) or Cd(II)) of an MT peptide entails the
increase of its monovalent metal ion-preference (Cu(I)) and vice versa
[3], it was plausible to hypothesize that SpMTB would exhibit a more
accentuated Cu-thionein character than SpMTA. Thus, we thoroughly
considered the results of recombinantly synthesizing both isoforms,
and their independent domains, in copper-supplemented E. coli cells.3.3. Cu-binding abilities: SpMTB exhibits a stronger Cu-thionein
character than SpMTA
Two different types of preparations were obtained for SpMTA
when synthesized in Cu-supplemented E. coli cells, depending on
the aeration conditions of the corresponding bacterial cultures (cf.
Table 3). Although in both cases SpMTA was recovered as a mix-
ture of Zn, Cu heteronuclear species, the average Zn content of the
preparation was always higher in the normally aerated culture, with
concomitant average lower Cu content (5.5 Cu:3.0 Zn), and with the
opposite results for the low aeration conditions (8.7 Cu:1.7 Zn). In
concordance with these ICP-AES results, in the former case the most
abundant detected species by ESI-MS was M4-SpMTA, followed by a
collection of higher nuclearity complexes (M5–M9, Fig. 8(A)), which
should be mainly consisting of Cu4Znx complexes (1< x < 5), since
ESI-MSdata at pH2.5 identiﬁed a highly predominant Cu4 cluster (Fig.
8(B)). Conversely, when SpMTA was synthesized under low aeration,
the most abundant species in solution switched to M8 (M = Zn + Cu),
readily followed by M9–M11 complexes (Fig. 8(C)), whose acid ESI-
MS analyses revealed to be built by Cu8 and Cu9 cores (Fig. 8(D)) plus
some added Zn(II) ions. The homologous SpMTBwas also synthesized
under both culture conditions. Under normal aeration, this isoform
yielded preparations similar to those of SpMTAwhen produced under
low aeration, i.e. a predominant M8 complex accompanied byM9 and
M10 species that acid ESI-MS identiﬁed as predominant Cu8Zn y com-
plexes (Table 4, Fig. 8(E) and (F)). With respect to the recombinant
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Fig. 5. CD spectra corresponding to the entire MT (A) and the separate constitutive α
(B) and β (C) domains of SpMTA (black) and SpMTB (red) recombinantly synthesized
in Cd-supplemented media. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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αu-SpMTB synthesis at low aeration, ICP-AES results indicate the for-
ation of homometallic Cu species (averagemetal content of 14.5 Cu/
T and absence of Zn(II) ions, Table 4). Unfortunately, due to the low
oncentration of the sample, possibly due to an intrinsic poor folding
f these complexes (as pointed out by their CD spectra, Fig. 9), ESI-MS
etection of the corresponding species was repeatedly unsuccessful.
ince the less aerated an E. coli culture, the higher the Cu content of
he grown cells, it is obvious that the capacity of SpMTB to exhibit,
ven under lower Cu assayed concentrations, the Cu(I)-binding be-
avior that SpMTA is only able to perform in the presence of higher
opper amounts, argues in favor of the increased Cu-thionein char-
cter of the former. It is worth noting that the major stoichiometries
eported here for both SpMT isoforms (i.e. Cu4Znx and Cu8Zny) have
lso been reported for mammalianMT1 [24,25] andMT3 [26], mussel
e-MT-10-IV [20], or nematode CeMT1 and CeMT2 [27], this indicat-
ng that this set of approximately 60-residueMTs commonly fold into
lusters containing a multiple of 4 Cu(I) ions complemented with a
ariable number of Zn(II) ions.
Again, the characterization of the Cu(I) binding abilities of the
eparate domains of both SpMT isoforms proved to be a valuable tool
o conﬁrm and further analyze the higher Cu-thionein character of
pMTB regarding SpMTA. First unforeseen information was that both
moieties showed distinct Cu(I) binding behavior, contrarily to whatwas observed for divalent metal ions. Hence, αSpMTA yielded, un-
der all assay conditions, mixtures of Zn, Cu heterometallic complexes
with highly oxidized and/or poorly metalated species, together with
dimeric complexes (Table 3),which exhibit almost ﬂat CDﬁngerprints
(Fig. 9(C) and (D)). Contrarily,αSpMTB invariably yieldedwell deﬁned
results: at regular oxygenation Cu5-, Cu4Zn1-, Cu4- and Cu7-αSpMTB
were the predominant species (Fig. 10(A) and (D), Table 4), and at low
aeration conditions a mixture of homometallic Cu complexes with
major Cu4 and Cu5 stoichiometries was detected (Fig. 10(F), Table 4).
These results were consistentwithwell-deﬁned CD spectra, typical of
Cu-MT chromophores, despite the fact that they exhibited rather low
intensity (Fig. 9(C) and (D)). Contrarily to the α domains, no signiﬁ-
cant differences could be detected for the recombinantly synthesized
β peptides in copper-supplemented media. At normal aeration both
isoformsyield amixture of specieswith close averageZn/MT(0.2) and
Cu/MT (3.3–5.1) ratios (Tables 3 and 4) and very similar CD spectra
(Fig. 9(E)), where M5 is the major species present (Fig. 10(B) and (C)).
ESI-MS at pH 2.5 (Fig. 10(E)) conﬁrmed the almost quasi homometal-
lic nature of the Cu-βSpMTB preparations, and comparison with data
at pH 7.0 allowed to deduce that the M5 major species corresponds
to a mixture of Cu5 and Cu4Zn1 complexes. At low aeration, very di-
luted samples were obtained and consequently very weak CD spectra
were recorded (Fig. 9(F)). However, βSpMTA ESI-MS analysis at pH
7.0 (Fig. 10(G)) shows a heterometallic species distribution similar to
that observed at normal oxygenation, with a major M5 form (Table
3). In view of the results obtained in the recombinant syntheses of
the βSpMT fragments, and in order to have a more precise picture of
their differential behavior when coordinating Cu(I), Zn/Cu titrations
were performed and followed through their CD spectra evolution. In
the case of βSpMTA, themaximumdegree of foldingwas achieved for
3–4 Cu(I) equivalents added to the Zn(II)-βSpMTA preparation, with
little further variation (Fig. 11(A)–(C)). Contrastingly,βSpMTBreaches
its maximum folding after 6 Cu(I) equivalents added (Fig. 11(D)–(F)),
which is in concordancewith a greater Cu(I) binding capacity. Finally,
when comparing these results with those of the recombinant com-
plexes, it becomes obvious that the CD spectrum of βSpMTA is fully
reproduced after 4 Cu(I) equivalents added (Fig. 11(G)), whereas for
βSpMTB, the highest CD spectra resemblance is attained after 7 Cu(I)
equivalents added (Fig. 11(H)).
4. Conclusions
From the set of data reported in this work, a differential metal ion
binding preference is envisaged for SpMTAand SpMTB, since different
results attribute a more pronounced Cu-thionein character to SpMTB
than to SpMTA, and vice versa for the Zn(II) and Cd(II)-thionein char-
acter. In summary, and according to the criteria proposed to evaluate
thepreference of a givenMTpeptide either formonovalent or divalent
metal ion coordination [3], it is worth noting that (i) SpMTA is able
to fold into almost unique and sulﬁde-free Zn(II) or Cd(II)-complexes,
while for these metal ions SpMTB yields preparations containing a
large variety of species, andwith a signiﬁcant sulﬁde content; and (ii)
SpMTB is able to yield, at standardbacterial cell copper concentrations
(i.e. normal aeration of the E. coli cultures), Cu-complexes that SpMTA
is only able to produce in higher-copper environments. Dissection of
the metal-binding abilities of both isoforms into their domains sug-
gests that while the β domain would be the only one responsible for
the diminished divalent metal binding capacity of SpMTB, both do-
mains would contribute to the enhanced capacity of SpMTB for Cu(I)
binding.
The differential Zn/Cu binding performance of SpMTA and SpMTB
suggests that both isoforms exert at least partially distinct comple-
mentary functions in the physiology of sea urchins. For divalentmetal
ions, SpMTA may be mostly responsible for housekeeping Zn home-
ostasis, while SpMTBwould only come into play under Zn or Cd over-
load emergency situations. This hypothesis is supported by the fact
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Fig. 6. CD spectra recorded during the titration of Zn4-αSpMTA with Cd(II) at pH 7 (A) and superimposition of CD spectra of Cd4-αSpMTA obtained by Zn/Cd substitution over
Zn4-αSpMTA (in vitro; black) and by recombinant synthesis in Cd-enriched media (in vivo; red) (B). (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
Fig. 7. CD spectra recorded during the titrations of Zn-βSpMTA (A, B) and Zn-βSpMTB (C, D) with Cd(II) at pH 7. The effect of the addition of S2− to βSpMTB is also shown (F), as
well as the CD superimposition of in vivo (red) and in vitro (black) Cd-βSpMTA (E) and Cd-βSpMTB (G) species obtained after addition of 3 Cd(II) equivalents to Zn-βSpMTA or after
an acidiﬁcation/reneutralization process of Cd-βSpMTB plus addition of 3 S2− equivalents. (For interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)that SpMTA is constitutively expressed at a higher rate than SpMTB
at low Zn concentrations, while increased divalent metal ion concen-
trations induce SpMTB expression up to similar values than SpMTA
[8], analogously to what has been described for the nematode CeMT1
and CeMT2 isoforms [27]. Interestingly, the existence of multiple MT
isoforms involved in different physiological roles has been very re-
cently conﬁrmed in another sea urchin species, Paracentrotus lividus,
in which its ﬁve different MT isogenes respond disctinctively to Cdtranscriptional activation, thus showing a certain degree of evolu-
tive functional differentiation [28]. Unfortunately, no information is
available for the copper physiology in sea urchin, or for copper re-
quirements during its development stages, or for the response of
both SpMT isogenes to copper overload. It would not be far-fetched
to assume that SpMTB, given its higher Cu-thionein character, could
better perform some function related to Cu metabolism in this group
of organisms. Overall, and as for other taxa inwhichMTpeptides have
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Fig. 8. Representative charge states for the ESI-MS spectra recorded at pH 7.0 and pH 2.5 of recombinant SpMTA (A, B) and SpMTB (E, F) synthesized in Cu-supplemented E. coli
media at normal aeration (N.A.) conditions, and of recombinant Cu-SpMTA (C, D) obtained at low aeration (L.A.) conditions. The observed species are collected in Tables 3 and 4.
Fig. 9. CD spectra corresponding to the entire MT (A, B) and the separate constitutive α (C, D) and β (E, F) domains of SpMTA (black) and SpMTB (red) recombinantly synthesized in
Cu-supplemented media at normal aeration (N.A.) and low aeration (L.A.) conditions (left and right, respectively). (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article.)
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Fig. 10. Representative charge states for the ESI-MS spectra of recombinant αSpMTB (A, D, F), βSpMTA (B, G) and βSpMTB (C, E) synthesized in Cu-supplemented E. coli media at
normal (N.A.) and low (L.A.) aeration conditions. M-MT species where M = Zn + Cu are assigned in spectra recorded at pH 7.0 (A–C, G), while Cu-MT species are assigned when
recorded at pH 2.5 (D–F). The observed species are collected in Tables 3 and 4.
Fig. 11. CD spectra recorded during the titration of Zn-βSpMTA (A–C) and Zn-βSpMTB (D–F) with Cu(I) at pH 7. Also, a comparison with the CD spectrum of the corresponding
recombinant Cu-βMT samples obtained at normal aeration conditions (in red) is shown (G, H). (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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etal ion binding properties would underlie the observed polymor-
hism, even when the involved polypeptides share a 85% sequence
dentity, as is the case for S. purpuratusMTs.
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